PCR43 A Review of Migraine-Related Pros in FDA Labelling Claims (2018-2023)

Dec 1, 2023, 00:00 AM
10.1016/j.jval.2023.09.2482
https://www.valueinhealthjournal.com/article/S1098-3015(23)05612-7/fulltext
Section Title :
Section Order : 11824
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)05612-7&doi=10.1016/j.jval.2023.09.2482
HEOR Topics :
Tags :
Regions :